Ligand Pharmaceuticals
LGND
#2815
Rank
S$7.57 B
Marketcap
S$378.86
Share price
-2.62%
Change (1 day)
44.41%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): S$79.11 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are S$0.25 Billion. In 2025 the company made an earning of S$0.21 Billion, an increase over its 2024 earnings that were of S$7.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$79.11 M-62.51%
2025 S$0.21 B2848.57%
2024 S$7.15 M-91.37%
2023 S$82.93 M-7.59%
2022 S$89.74 M4%
2021 S$86.29 M296.42%
2020 S$21.76 M-97.97%
2019 S$1.07 B275.62%
2018 S$0.28 B237.48%
2017 S$84.67 M49.05%
2016 S$56.8 M55.41%
2015 S$36.55 M36.87%
2014 S$26.7 M29.59%
2013 S$20.6 M1309.35%
2012 S$1.46 M-43.97%
2011 S$2.6 M-113.19%
2010 -S$19.79 Million59.86%
2009 -S$12.38 Million-61.33%
2008 -S$32.01 Million-58.75%
2007 -S$77.6 Million20.52%
2006 -S$64.39 Million81.27%
2005 -S$35.52 Million
2003 -S$24.73 Million-20.6%
2002 -S$31.15 Million4.38%
2001 -S$29.84 Million-48.83%
2000 -S$58.31 Million-19.74%
1999 -S$72.65 Million-19.06%
1998 -S$89.75 Million126.71%
1997 -S$39.59 Million-5.83%
1996 -S$42.04 Million136.23%
1995 -S$17.8 Million-33.97%
1994 -S$26.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.13 B 30,636.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.98 B 11,340.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$44.83 B 56,983.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$14.25 B 18,045.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-S$0.25 Billion-407.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$8.66 B 10,937.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.61 B 18,504.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$9.22 B 11,646.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-S$79.8 Million-201.60%๐Ÿ‡บ๐Ÿ‡ธ USA